Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.
Snell Taylor SJ, Nielson CM, Breskin A, Saul B, Yu Y, Alam N, Eisen M, Hippenmeyer J, Janssens A, Kozak T, Papadaki HA, Selleslag D, Viallard JF, Feistritzer C, Kaiafa G, Kelsh M, Kilpatrick K, Brookhart MA, McGrath LJ.
Snell Taylor SJ, et al. Among authors: alam n.
Adv Ther. 2021 May;38(5):2673-2688. doi: 10.1007/s12325-021-01727-5. Epub 2021 Apr 18.
Adv Ther. 2021.
PMID: 33866516
Free PMC article.